Skip to content

Fulgent Genetics, Inc. FLGT Compensation and benefits

Discontinued — last reported Q3 '22

Compensation and benefits at other companies

Revvity logo
RevvityRVTY
Bio-Rad Laboratories logo
Bio-Rad LaboratoriesBIO

Segments

By segment

See full
Laboratory Services$7.64M-10.5%
Therapeutic Development$2.25M+11.5%

Other financials

Income statement

See full
Revenue$71.1M-3.2%
Gross profit$21.5M-24.2%
Operating income-$34.6M-74.9%
Net income-$24.8M-115%
EPS (diluted)-$0.80-116%

Balance sheet

See full
Cash & equivalents$23.4M-65.2%
Total debt$8.2M+40.5%
Total equity$1.0B-6.9%
Total assets$1.2B-4.1%

Cash flow

See full
Operating cash flow$7.1M+260%
CapEx$5.2M+10.3%
Free cash flow$1.9M+121%

Valuation

See full
Market cap$552.11M-7.1%
Enterprise value$536.92M+0.7%
P/S1.7×-0.3×

Profitability

See full
Gross margin38.7%-0.1pp
Operating margin-33.1%+17.4pp
Net margin-23%+43.3pp
FCF margin-36.9%

Returns & leverage

See full
Return on equity-6.8%+48.2pp
Debt / equity0.0×
Current ratio5.3×-1.0×

Where this comes from

Reported directly by Fulgent Genetics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:ShareBasedCompensation.

The official record: Fulgent Genetics, Inc.’s 10-Q, filed November 7, 2022, on SEC EDGAR. View the filing →

Ask your AI about Fulgent Genetics, Inc.'s compensation and benefits.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Fulgent Genetics, Inc.'s compensation and benefits?
Fulgent Genetics, Inc. (FLGT) reported compensation and benefits of $8.97M in Q3 2022.
How has Fulgent Genetics, Inc.'s compensation and benefits changed year-over-year?
Fulgent Genetics, Inc.'s compensation and benefits increased by 105.1% year-over-year, from $4.37M to $8.97M.
What does compensation and benefits mean?
Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.